Skip to main content

1000minds used to prioritize drug-resistant bacterial infections to guide R&D into new antibiotics

The World Health Organization used 1000minds to create a Priority Pathogens List (PPL) of antibiotic-resistant bacteria to support R&D into new and effective drugs.

1000minds used to prioritize drug-resistant bacterial infections to guide R&D into new antibiotics

Millions of people could die each year if new and effective antibiotics are not developed to control antibiotic-resistant bacteria that are increasing becoming a global threat. The World Health Organization (WHO) developed a Priority Pathogens List (PPL) of antibiotic-resistant bacteria to support research and development into new and effective drugs.

1000minds was used to survey and aggregate the preferences of experts in infectious diseases from around the world.

Too few antibiotics in pipeline to tackle global drug-resistance crisis, WHO warns”, The Guardian, 19 Sep 2017

The world may soon run out of antibiotics”, Newsweek, 19 Sep 2017

WHO: Antibiotic-resistant infections are a ‘global health emergency’, CBS Miami, 19 Sep 2017

Not enough new antibiotics in the pipeline, UN report warns”, UN News Centre, 20 Sep 2017

World Health Org warns lack of stronger antibiotics is a ‘global health emergency’”, New York Daily Times, 20 Sep 2017

WHO report sounds alarm over antibiotics and drug resistance”, Africa Times, 20 Sep 2017

‘Global emergency’: World running out of antibiotics, warns WHO ”, RT, 20 Sep 2017

World running out of antibiotics, resistant infections growing, warn World Health Organization”, India TV, 20 Sep 2017

WHO says world is running out of antibiotics”, The Independent, 20 Sep 2017

Antibiotics resistance a ‘global emergency’”, Times of Malta, 21 Sep 2017

WHO report

K Weyer, E Tacconelli, N Magrini & Co-ordinating Group (2017), “Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis”, World Health Organization (WHO/EMP/IAU/2017.12) News release »

Article

E Tacconelli, E Carrara, A Savoldi et al and the WHO Pathogens Priority List working group (2018), “Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis”, The Lancet Infectious Diseases 18, 318-27.

Have confidence in your decisions

1000minds has 20 years’ experience working with clinicians and researchers to create valid and reliable systems for healthcare decision-making, including prioritizing patients for elective services, health technology prioritization, disease classification, disease R&D targeting, health preferences research, and more. See our health sector case studies.

The ‘secret spice’ behind our innovative approach is our award-winning, patented PAPRIKA method for conjoint analysis and multi-criteria decision-making (MCDM).

Curious about how 1000minds can help you? Sign up for our free trial or book a demo with our friendly team today.  

Share this post on: